Moreover, β-catenin signaling within tumor cells can shape the immune microenvironment around them, as it was shown that melanoma cells with elevated levels of CTNNB1 in the nucleus express IL10 and IL12, which promote immunosuppression. This evidence concerns the gene CTNNB1 and neoplasm.